Akso Health Group (NASDAQ: AHG) Stock Competitors & Peer Comparison

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, VRSK has a market cap of 24.2B. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while VRSK trades at $185.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas VRSK's P/E ratio is 25.68. In terms of profitability, AHG's ROE is -0.50%, compared to VRSK's ROE of -2.12%. Regarding short-term risk, AHG is more volatile compared to VRSK. This indicates higher risk in terms of short-term price fluctuations for AHG.Check VRSK's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, CART has a market cap of 11.8B. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while CART trades at $50.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas CART's P/E ratio is 24.31. In terms of profitability, AHG's ROE is -0.50%, compared to CART's ROE of +0.18%. Regarding short-term risk, AHG is more volatile compared to CART. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CART's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, TTD has a market cap of 6.8B. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while TTD trades at $14.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas TTD's P/E ratio is 13.24. In terms of profitability, AHG's ROE is -0.50%, compared to TTD's ROE of +0.16%. Regarding short-term risk, AHG is more volatile compared to TTD. This indicates higher risk in terms of short-term price fluctuations for AHG.Check TTD's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, LFTO has a market cap of 4.2B. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while LFTO trades at $20.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas LFTO's P/E ratio is 66.47. In terms of profitability, AHG's ROE is -0.50%, compared to LFTO's ROE of -0.06%. Regarding short-term risk, AHG is less volatile compared to LFTO. This indicates lower risk in terms of short-term price fluctuations for AHG.Check LFTO's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, TCGL has a market cap of 3.5B. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while TCGL trades at $172.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas TCGL's P/E ratio is -5761.33. In terms of profitability, AHG's ROE is -0.50%, compared to TCGL's ROE of -1.33%. Regarding short-term risk, AHG is less volatile compared to TCGL. This indicates lower risk in terms of short-term price fluctuations for AHG.Check TCGL's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, IOND has a market cap of 2.5B. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while IOND trades at $66.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas IOND's P/E ratio is -9.96. In terms of profitability, AHG's ROE is -0.50%, compared to IOND's ROE of N/A. Regarding short-term risk, AHG is more volatile compared to IOND. This indicates higher risk in terms of short-term price fluctuations for AHG.Check IOND's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, TRUE has a market cap of 225.9M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while TRUE trades at $2.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas TRUE's P/E ratio is -12.10. In terms of profitability, AHG's ROE is -0.50%, compared to TRUE's ROE of -0.12%. Regarding short-term risk, AHG is more volatile compared to TRUE. This indicates higher risk in terms of short-term price fluctuations for AHG.Check TRUE's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, AIB has a market cap of 138.3M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while AIB trades at $1.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas AIB's P/E ratio is -182.00. In terms of profitability, AHG's ROE is -0.50%, compared to AIB's ROE of -0.22%. Regarding short-term risk, AHG is more volatile compared to AIB. This indicates higher risk in terms of short-term price fluctuations for AHG.Check AIB's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, ROC has a market cap of 87.4M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while ROC trades at $4.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas ROC's P/E ratio is -16.80. In terms of profitability, AHG's ROE is -0.50%, compared to ROC's ROE of -0.75%. Regarding short-term risk, AHG is more volatile compared to ROC. This indicates higher risk in terms of short-term price fluctuations for AHG.Check ROC's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, ZGM has a market cap of 80.2M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while ZGM trades at $6.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas ZGM's P/E ratio is 67.90. In terms of profitability, AHG's ROE is -0.50%, compared to ZGM's ROE of +0.72%. Regarding short-term risk, AHG is less volatile compared to ZGM. This indicates lower risk in terms of short-term price fluctuations for AHG.Check ZGM's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, GIFT has a market cap of 30.7M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while GIFT trades at $0.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas GIFT's P/E ratio is -3.46. In terms of profitability, AHG's ROE is -0.50%, compared to GIFT's ROE of -0.40%. Regarding short-term risk, AHG is more volatile compared to GIFT. This indicates higher risk in terms of short-term price fluctuations for AHG.Check GIFT's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, ZSQR has a market cap of 25.9M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while ZSQR trades at $4.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas ZSQR's P/E ratio is -1.48. In terms of profitability, AHG's ROE is -0.50%, compared to ZSQR's ROE of -0.83%. Regarding short-term risk, AHG is more volatile compared to ZSQR. This indicates higher risk in terms of short-term price fluctuations for AHG.Check ZSQR's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, HOLO has a market cap of 23.1M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while HOLO trades at $1.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas HOLO's P/E ratio is -0.02. In terms of profitability, AHG's ROE is -0.50%, compared to HOLO's ROE of +0.01%. Regarding short-term risk, AHG is more volatile compared to HOLO. This indicates higher risk in terms of short-term price fluctuations for AHG.Check HOLO's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, FNGR has a market cap of 16.9M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while FNGR trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas FNGR's P/E ratio is -2.30. In terms of profitability, AHG's ROE is -0.50%, compared to FNGR's ROE of -0.47%. Regarding short-term risk, AHG is less volatile compared to FNGR. This indicates lower risk in terms of short-term price fluctuations for AHG.Check FNGR's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, SST has a market cap of 16.7M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while SST trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas SST's P/E ratio is -0.20. In terms of profitability, AHG's ROE is -0.50%, compared to SST's ROE of -11.81%. Regarding short-term risk, AHG is less volatile compared to SST. This indicates lower risk in terms of short-term price fluctuations for AHG.Check SST's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, AGAE has a market cap of 16.6M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while AGAE trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas AGAE's P/E ratio is -0.54. In terms of profitability, AHG's ROE is -0.50%, compared to AGAE's ROE of -0.76%. Regarding short-term risk, AHG is more volatile compared to AGAE. This indicates higher risk in terms of short-term price fluctuations for AHG.Check AGAE's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, CHAI has a market cap of 6.4M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while CHAI trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas CHAI's P/E ratio is 0.03. In terms of profitability, AHG's ROE is -0.50%, compared to CHAI's ROE of -3.61%. Regarding short-term risk, AHG is more volatile compared to CHAI. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CHAI's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, QCLS has a market cap of 5.1M. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while QCLS trades at $2.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas QCLS's P/E ratio is -1.06. In terms of profitability, AHG's ROE is -0.50%, compared to QCLS's ROE of -0.65%. Regarding short-term risk, AHG is more volatile compared to QCLS. This indicates higher risk in terms of short-term price fluctuations for AHG.Check QCLS's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, CRTN has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while CRTN trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas CRTN's P/E ratio is -0.63. In terms of profitability, AHG's ROE is -0.50%, compared to CRTN's ROE of -1.79%. Regarding short-term risk, AHG is more volatile compared to CRTN. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CRTN's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, HDP has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while HDP trades at $14.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas HDP's P/E ratio is -6.88. In terms of profitability, AHG's ROE is -0.50%, compared to HDP's ROE of +7.62%. Regarding short-term risk, AHG is more volatile compared to HDP. This indicates higher risk in terms of short-term price fluctuations for AHG.Check HDP's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, CRA has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while CRA trades at N/A.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas CRA's P/E ratio is N/A. In terms of profitability, AHG's ROE is -0.50%, compared to CRA's ROE of -0.59%. Regarding short-term risk, AHG is not fully comparable compared to CRA. This indicates unavailable risk data in terms of short-term price fluctuations for AHG.Check CRA's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, CSC has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while CSC trades at $10.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas CSC's P/E ratio is -6.61. In terms of profitability, AHG's ROE is -0.50%, compared to CSC's ROE of -0.05%. Regarding short-term risk, AHG is more volatile compared to CSC. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CSC's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, PRGY has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while PRGY trades at N/A.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas PRGY's P/E ratio is N/A. In terms of profitability, AHG's ROE is -0.50%, compared to PRGY's ROE of +3.63%. Regarding short-term risk, AHG is not fully comparable compared to PRGY. This indicates unavailable risk data in terms of short-term price fluctuations for AHG.Check PRGY's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, DST has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while DST trades at $83.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas DST's P/E ratio is N/A. In terms of profitability, AHG's ROE is -0.50%, compared to DST's ROE of +0.38%. Regarding short-term risk, AHG is more volatile compared to DST. This indicates higher risk in terms of short-term price fluctuations for AHG.Check DST's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, FUEL has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while FUEL trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas FUEL's P/E ratio is -1.76. In terms of profitability, AHG's ROE is -0.50%, compared to FUEL's ROE of -0.59%. Regarding short-term risk, AHG is more volatile compared to FUEL. This indicates higher risk in terms of short-term price fluctuations for AHG.Check FUEL's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, IMPV has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while IMPV trades at $55.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas IMPV's P/E ratio is -68.74. In terms of profitability, AHG's ROE is -0.50%, compared to IMPV's ROE of +0.08%. Regarding short-term risk, AHG is more volatile compared to IMPV. This indicates higher risk in terms of short-term price fluctuations for AHG.Check IMPV's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, RMGN has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while RMGN trades at $1.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas RMGN's P/E ratio is -1.86. In terms of profitability, AHG's ROE is -0.50%, compared to RMGN's ROE of -0.66%. Regarding short-term risk, AHG is more volatile compared to RMGN. This indicates higher risk in terms of short-term price fluctuations for AHG.Check RMGN's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, DWRE has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while DWRE trades at $74.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas DWRE's P/E ratio is -62.71. In terms of profitability, AHG's ROE is -0.50%, compared to DWRE's ROE of -0.13%. Regarding short-term risk, AHG is more volatile compared to DWRE. This indicates higher risk in terms of short-term price fluctuations for AHG.Check DWRE's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, ACTA has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while ACTA trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas ACTA's P/E ratio is 0.18. In terms of profitability, AHG's ROE is -0.50%, compared to ACTA's ROE of -0.07%. Regarding short-term risk, AHG is more volatile compared to ACTA. This indicates higher risk in terms of short-term price fluctuations for AHG.Check ACTA's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, CALD has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while CALD trades at $36.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas CALD's P/E ratio is -115.41. In terms of profitability, AHG's ROE is -0.50%, compared to CALD's ROE of -0.08%. Regarding short-term risk, AHG is more volatile compared to CALD. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CALD's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, XTLY has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while XTLY trades at $15.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas XTLY's P/E ratio is -28.98. In terms of profitability, AHG's ROE is -0.50%, compared to XTLY's ROE of -2.17%. Regarding short-term risk, AHG is more volatile compared to XTLY. This indicates higher risk in terms of short-term price fluctuations for AHG.Check XTLY's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 1.1B. In comparison, DWCH has a market cap of 0. Regarding current trading prices, AHG is priced at $1.30 on the NASDAQ, while DWCH trades at $13.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -6.09, whereas DWCH's P/E ratio is -15.29. In terms of profitability, AHG's ROE is -0.50%, compared to DWCH's ROE of -0.31%. Regarding short-term risk, AHG is more volatile compared to DWCH. This indicates higher risk in terms of short-term price fluctuations for AHG.Check DWCH's competition here